MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
TWAV
TaoWeave, Inc.
There isn't enough reported data to score TWAV yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
TWAV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| N/A | |
| N/A |
TWAV's revenue is currently stable, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like TWAV.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | โ |
| Current | 15x | $189 | โ |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
TWAV PE Valuation
TWAV has no meaningful PE right now: it lost money over the past year.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
TWAV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect TWAV's revenue to decline, with its earnings and profitability holding steady.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the stronger earnings trend. Trailing diluted EPS is up 29% for MS versus TWAV down 101%.
TWAV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$91.78 | +$334.22 |
| Q2 2023 | -$217.78 | +$82.22 |
| Q1 2023 | -$360.58 | -$186.58 |
| Q4 2022 | -$426.58 | -$204.58 |
| Q3 2022 | -$426.00 | -$330.00 |
| Q2 2022 | -$300.00 | +$24.00 |
| Q1 2022 | -$174.00 | +$492.00 |
| Q4 2021 | -$222.00 | +$666.00 |
TWAV lost $2.20 per share over the past year, a smaller loss than the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over TWAV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over TWAV on profitability, with a higher operating margin.
TWAV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $522K | -12% |
| Q1 2026 | $707K | +14% |
| Q4 2025 | $622K | +10% |
| Q3 2025 | $601K | +4% |
| Q2 2025 | $592K | -3.1% |
| Q1 2025 | $622K | -0.6% |
| Q4 2024 | $563K | -40% |
| Q3 2024 | $578K | -34% |
TWAV's revenue is growing: $522,000 last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -161% | -46 points |
| Q1 2026 | -79% | +32 points |
| Q4 2025 | -126% | +39 points |
| Q3 2025 | -133% | +52 points |
| Q2 2025 | -115% | +51 points |
| Q1 2025 | -111% | +78 points |
| Q4 2024 | -165% | -30 points |
| Q3 2024 | -185% | -79 points |
TWAV's operating margin was โ161% last quarter, down 46 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS has the edge over TWAV on cash flow, with more consistent year-over-year improvement.
TWAV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$539K | -$502K |
| Q1 2026 | -$650K | +$30K |
| Q4 2025 | -$744K | +$141.2K |
| Q3 2025 | -$1.6M | -$643K |
| Q2 2025 | -$37K | +$943K |
| Q1 2025 | -$680K | -$50K |
| Q4 2024 | -$885.2K | -$180.2K |
| Q3 2024 | -$911K | -$805K |
TWAV's free cash flow was โ$3M over the past year, against โ$3M the year before. Free cash flow isn't a meaningful measure for financial services companies like TWAV.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
TWAV Net Leverage
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
TWAV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 19.8 | Oversold |
TWAV's weekly RSI is 43 (neutral) and its Stochastic is 20 (oversold).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
TWAV PE vs Financial Services Sector
TWAV has no meaningful PE right now: it lost money over the past year.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over TWAV on trend strength, trading above more of its moving averages.
TWAV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.41 | 12% below |
| 20 week MA | $1.35 | 8.1% below |
| 50 week MA | $1.49 | 17% below |
| 100 week MA | $2.39 | 48% below |
| 200 week MA | $14.6 | 92% below |
TWAV is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over TWAV on returns for 2026, with the stronger performance.
TWAV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $894.0 | $3,306.0 | +270% |
| 2021 | $3,306.0 | $648.0 | -80% |
| 2022 | $648.0 | $72.0 | -89% |
| 2023 | $72.0 | $8.00 | -89% |
| 2024 | $8.00 | $3.88 | -52% |
| 2025 | $3.88 | $1.97 | -49% |
| 2026 YTD | $1.97 | $1.24 | -37% |
TWAV has finished five years in a row lower, and it's down 37% so far in 2026.